Dosage regimen for prasugrel

Details for Australian Patent Application No. 2006259538 (hide)

Owner Eli Lilly and Company

Inventors Jakubowski, Joseph Anthony; Brandt, John Thomas; Payne, Christopher David; Weerakkody, Govinda Jayanath; Winters, Kenneth John; Farid, Nagy Alphonse

Agent Spruson & Ferguson

Pub. Number AU-A-2006259538

PCT Pub. Number WO2006/138317

Priority 60/691,740 17.06.05 US

Filing date 13 June 2006

Wipo publication date 28 December 2006

International Classifications

A61K 31/47 (2006.01) - Quinolines

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/138317 Priority application(s): WO2006/138317

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259543-Total amino acid stabilization during cell-free protein synthesis

2006259536-Anti-IGF1R antibody formulations